Cargando…

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study

BACKGROUND: Benefits using the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness of PCV13 vaccination in preventing hospitalisation from pneumonia among middle-aged and older adults. METHODS: Population-based cohort study inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vila-Corcoles, Angel, Ochoa-Gondar, Olga, de Diego, Cinta, Satue, Eva, Aragón, María, Vila-Rovira, Angel, Gomez-Bertomeu, Frederic, Magarolas, Ramon, Figuerola-Massana, Enric, Raga, Xavier, Perez, Mar O., Ballester, Frederic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921259/ https://www.ncbi.nlm.nih.gov/pubmed/29699550 http://dx.doi.org/10.1186/s12879-018-3096-7

Ejemplares similares

Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017
por: Vila-Córcoles, Angel, et al.
Publicado: (2019)

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
por: Vila-Corcoles, Angel, et al.
Publicado: (2012)

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018
por: Vila-Córcoles, Angel, et al.
Publicado: (2023)

Vacunación antineumocócica en adultos de Cataluña: coberturas y grado de adecuación a distintas guías de recomendaciones
por: Ochoa-Gondar, Olga, et al.
Publicado: (2018)

COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March–June 2020
por: Vila-Corcoles, Angel, et al.
Publicado: (2021)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain
por: Satué-Gracia, Eva M., et al.
Publicado: (2022)

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain
por: Satué-Gracia, Eva M., et al.
Publicado: (2022)

Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study
por: Ochoa-Gondar, Olga, et al.
Publicado: (2023)

Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings
por: Vila-Corcoles, Angel, et al.
Publicado: (2021)

Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain
por: Vila-Córcoles, Angel, et al.
Publicado: (2020)

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia
por: Vila-Corcoles, Angel, et al.
Publicado: (2009)

Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study
por: Ochoa-Gondar, O., et al.
Publicado: (2017)

Enfermedad neumocócica en el adulto: niveles de riesgo y recomendaciones de vacunación
por: Vila-Córcoles, Angel, et al.
Publicado: (2017)

Epidemiología de la neumonía neumocócica en adultos mayores de 50 años: estudio de cohortes en Cataluña, 2017-2018
por: Ochoa-Gondar, Olga, et al.
Publicado: (2023)

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
por: Vila-Córcoles, Angel, et al.
Publicado: (2006)

Pneumococcal vaccination in times of COVID-19()
por: Vila Córcoles, Ángel
Publicado: (2022)

Utilidad de la escala de severidad modificada CRB75 en el manejo del paciente anciano con neumonía adquirida en la comunidad()
por: Ochoa Gondar, Olga, et al.
Publicado: (2013)

Indicadores pronósticos de la COVID-19 en atención primaria
por: Satué Gracia, Eva María, et al.
Publicado: (2022)

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study
por: Ochoa-Gondar, Olga, et al.
Publicado: (2008)

Vacunación antineumocócica en tiempos de COVID-19
por: Vila Córcoles, Ángel
Publicado: (2022)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly
por: Kislaya, Irina, et al.
Publicado: (2019)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
por: Gourzoulidis, George, et al.
Publicado: (2023)

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
por: Esposito, Susanna, et al.
Publicado: (2015)

Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
por: Schmoele-Thoma, Beate, et al.
Publicado: (2019)

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
por: Malene B, Mikkelsen, et al.
Publicado: (2023)

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
por: Ngamprasertchai, Thundon, et al.
Publicado: (2023)

Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine
por: Valente, Carina, et al.
Publicado: (2012)

Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil
por: Andrade, Ana Lucia, et al.
Publicado: (2014)

A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis
por: Tin Tin Htar , Myint, et al.
Publicado: (2013)

1430. Evolving Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease
por: Yildirim, Inci, et al.
Publicado: (2018)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
por: Earnshaw, Stephanie R, et al.
Publicado: (2012)

Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly
por: Seo, Yu Bin, et al.
Publicado: (2017)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
por: Kim, Hye-Young, et al.
Publicado: (2020)

Effect of Pneumococcal Conjugate 13 Valent and Polysaccharide 23 Valent Vaccination on Anti-Pneumococcal Antibody Titer of Hemodialysis Patients: A Randomized Clinical Trial
por: Shahi, Shima, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9il98aahftol4j790jn6jft421